News | October 14, 2022
Cytel to acquire SDS Life Science and SDS MedteQ
The move will add new global talent to Cytel’s Strategic Consulting group
The move will add new global talent to Cytel’s Strategic Consulting group
This win is on the back of a prestigious order from Reliance Life Sciences
Construction is now underway with the facility scheduled to be operational by 2025
Sud has more than 32 years of work experience with different companies like Clivient, Jubilant Life Sciences, Piramal Enterprises, Parabolic Drugs, Orchid Chemicals and Pharmaceuticals, Ranbaxy Labs, and Lupin
Rabies claims around 59,000 deaths globally a year, of which around 20,000 or just over one-third of the deaths take place in India alone
He has over two decades of rich experience in management consulting, advising and transforming leading generic pharmaceutical companies in India and global markets
SK Capital’s investment will serve as a catalyst for a new strategic direction as the Company seeks to deepen and expand its presence in fine chemistries for the global life science market.
Dr. Mahdavi will lead Ginkgo's commercial efforts in the growing areas of bio-reagents, cell and gene therapies and new biopharmaceutical modalities.
The acquisition reaffirms Infosys’ commitment to help global life sciences companies
The capital expansion program commenced in June 2022 and is expected to complete in 2024
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
